{
    "nct_id": "NCT05849207",
    "official_title": "IIT2022-03-Paquette-GeriBMT: A Phase I Study of De-Escalation of Post-Transplant Cyclophosphamide Dosing in Patients Aged >/= 65 Years Undergoing Conditioning With Fludarabine and Total Body Irradiation 800 cGy",
    "inclusion_criteria": "* Patient age >/= 65 years\n* Patient has a related donor who is a human leukocyte antigens (HLA) haploidentical match\n* Patient and Donor sign the Informed Consent Form for the study\n* Patient meets standard criteria for allogeneic stem cell transplant\n* Patient is deemed suitable to receive Flu/TBI 800 conditioning regimen as standard of care transplant\n* Donor is willing to donate peripheral blood stem cells (PBSC)\nHealthy volunteers allowed\nMust have minimum age of 65 Years",
    "exclusion_criteria": "* Patient has a diagnosis of myelofibrosis\n* Patient has high titer antibodies (>10,000 mean fluorescent intensity) against one or more donor HLA antigens\n* Patient has undergone prior autologous or allogeneic stem cell transplant\n* Inability to collect at least 3 x 10^6 CD34+ PBSCs/kg recipient weight from the donor\n* Requiring sedation for cardiac MRIs.\n* Prohibited Implants and/or Devices:\n\n  * Mechanical, magnetic or electrical activated implants (i.e. cardiac pacemakers, neurostimulators and infusion pumps)\n  * Ferromagnetic implants and ferromagnetic foreign bodies, such as intracranial, aneurysm clips, shrapnel and intraocular metal chips as these could become dislodged.\n* Subjects with claustrophobia, problems being in enclosed spaces, or inability to lie supine.",
    "miscellaneous_criteria": ""
}